Latest News about Tilray Medical
Recent news which mentions Tilray Medical
Cannabis Giant Tilray Expands Medical Marijuana Portfolio With Redecan Launch In Australia
September 18, 2024
From Benzinga
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
September 09, 2024
From Benzinga
New Study Shows High Use Of Medical Cannabis For Chronic Pain And Arthritis In Older Patients
July 15, 2024
Tickers
TLRY
From Benzinga
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
July 09, 2024
From Benzinga
Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
April 03, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Italians To Enjoy Medical Marijuana Offerings From One Of The Biggest Cannabis Companies In The World
May 25, 2023
Tickers
TLRY
From Benzinga
Tilray Launches 'Take Back Control' Platform To Provide Women With Free Medical Cannabis Resources
November 18, 2022
Tickers
TLRY
From Benzinga
Scientists Investigate: Does It Makes Sense To Deny Liver Transplants To Cannabis Users?
October 26, 2022
Tickers
TLRY
From Benzinga
Tilray's Medical Cannabis Oral Solution Approved For Pharmaceutical Distribution In Italy
September 22, 2022
Tickers
TLRY
From Benzinga
Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program
August 25, 2022
Tickers
TLRY
From Benzinga
Tilray Medical Launches Cannabis Education Platform 'WeCare-MedicalCannabis' Across Europe
July 19, 2022
Tickers
TLRY
From Benzinga
Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada
June 07, 2022
Tickers
TLRY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.